42 results
8-K
EX-1.1
WINT
Windtree Therapeutics Inc
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety
8-K
EX-1.1
WINT
Windtree Therapeutics Inc
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result
424B4
WINT
Windtree Therapeutics Inc
20 Apr 23
Prospectus supplement with pricing info
6:03pm
conditions negatively impact product quality. This may require changes to the formulation or manufacturing process for one or more of our product candidates
8-K
EX-1.1
a0zau42 w89mwom
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
S-1/A
EX-1.1
wab9k930
6 May 20
IPO registration (amended)
5:31pm
8-K
EX-10.1
yp9d0msdes2id7
9 Dec 19
Windtree Therapeutics Completes $26.4 Million Private Placement
5:09pm
8-K
EX-10.3
25cn pyx4wbzlp
21 Dec 18
Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company Targeting Cardiovascular and Respiratory Diseases
5:28pm